Daily cardiology

SGLT2 inhibition: Making waves in the heart failure landscape 12.01.2022 9:36 ↓

Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology

Cardiometabolic Grand Round (2) 12.01.2022 55:23 ↓

A brief talk on DM medication challenges in patients with CVD

Paradigm Shift in Treating Intermediate Risk Pulmonary Embolism 11.01.2022 1:04:25 ↓

Concise Talk on Intermediate Risk Pulmonary Embolism, update by an expert in the field

How to Implement the Newest Diabetes Therapies in HF Treatment 11.01.2022 23:03 ↓

New insight from EMPEROR Reduced Trial

What we learned from ESC Congress about HTN Management 11.01.2022 1:33:34 ↓

A Brief Discussion on HTN Management Pearls of ESC 2020

VTE Prophylaxis in Patients with COVID-19 11.01.2022 45:20 ↓

Challenges on VTE Prophylaxis in different settings (inpatient, outpatient, upon discharge)

ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion 11.01.2022 1:35:35 ↓

Brief Discussion on the New ESC Guideline on NSTE-ACS

Diabetes and Cardiovascular Diseases 11.01.2022 9:24 ↓

On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

Smoking and the Heart the Struggle Continues 11.01.2022 9:37 ↓

On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors

Ground-breaking research from ESC Congress 2020 (23) 11.01.2022 5:48 ↓

Part Twenty-three: Trial Review, ELDERCARE-AF

Ground-breaking research from ESC Congress 2020 (21) 11.01.2022 2:29 ↓

Part Twenty-One: Trial Review, BPLTTC (CANCER)

Ground-breaking research from ESC Congress 2020 (22) 11.01.2022 3:34 ↓

Part Twenty-Two: Trial Review, ATPCI

Ground-breaking research from ESC Congress 2020 (15) 10.01.2022 3:53 ↓

Part Fifteen: Trial Review, PARALLAX

Ground-breaking research from ESC Congress 2020 (17) 10.01.2022 4:08 ↓

Part Seventeen: Trial Review, REALITY

Ground-breaking research from ESC Congress 2020 (9) 10.01.2022 6:06 ↓

Part Nine: Trial Review, RATE-AF

Ground-breaking research from ESC Congress 2020 (11) 10.01.2022 4:40 ↓

Part Eleven: Trial Review, DAPA-CKD

Ground-breaking research from ESC Congress 2020 (14) 10.01.2022 3:27 ↓

Part Fourteen: Trial Review, POPULAR CABG

Ground-breaking research from ESC Congress 2020 (20) 10.01.2022 3:20 ↓

Part Twenty: Trial Review, POPULAR TAVI

Ground-breaking research from ESC Congress 2020 (19) 10.01.2022 2:31 ↓

Part Nineteen: Trial Review, EXPLORER-HCM

Ground-breaking research from ESC Congress 2020 (18) 10.01.2022 4:38 ↓

Part Eighteen: Trial Review, HOME-PE

Ground-breaking research from ESC Congress 2020 (4) 10.01.2022 3:20 ↓

Part Four: Trial Review, BRACE-CORONA

Ground-breaking research from ESC Congress 2020 (12) 10.01.2022 5:16 ↓

Part Twelve: Trial Review, EVAPORATE

Ground-breaking research from ESC Congress 2020 (16) 10.01.2022 5:02 ↓

Part Sixteen: Trial Review, BPLTTC

Ground-breaking research from ESC Congress 2020 (3) 10.01.2022 8:51 ↓

Part Three: Trial Review; THEMIS, PAD

Ground-breaking research from ESC Congress 2020 (1) 10.01.2022 4:38 ↓

Congress Coverage: Introduction